Significant De-leveraging Transaction Resulting in Overall Debt Reduction of Approximately $1.7 Billion THE WOODLANDS, Texas, Dec. 24, 2025 /PRNewswire/ --…
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical…
State-of-the-art facility expands company's global research and development capabilities THE WOODLANDS, Texas, Oct. 28, 2025 /PRNewswire/ -- SI Group, a…
New collaboration will expand SI Group's customer reach complementing its long-standing partnership with Brenntag THE WOODLANDS, Texas, Oct. 2, 2025…